Immunological study on brain tumor patients

Abstract

Current study aimed to accomplished by assessment levels of alkaline phosphatase and IL-12 levels in Iraqi patients with brain tumor. From November 2021 to February 2022, researchers at Al-Hussein Hospital in Karbala, Iraq, will investigate the prevalence of bacteremia and immunological markers in patients with brain tumors. 50 patients with brain tumors (27 males, 23 females) and 30 healthy people as control Both patients and controls had blood drawn. interleukin-12 (IL-12) by ELISA. The findings indicated that the most vulnerable age group was 1–10-year-old, with a 26% infection rate compared to other age groups. Interleukin-12 levels in patients are lower than in healthy controls